Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function
Open Access
- 9 June 2015
- journal article
- other
- Published by Springer Science and Business Media LLC in Journal of Neuroimmune Pharmacology
- Vol. 10 (2), 193-203
- https://doi.org/10.1007/s11481-015-9615-z
Abstract
No abstract availableKeywords
This publication has 127 references indexed in Scilit:
- Brain cannabinoid CB2 receptors modulate cocaine's actions in miceNature Neuroscience, 2011
- The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effectsNeuropharmacology, 2011
- Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the BedsideNeurotherapeutics, 2009
- CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injuryMicrovascular Research, 2009
- Modulation of Cannabinoid Receptor Activation as a Neuroprotective Strategy for EAE and StrokeJournal of Neuroimmune Pharmacology, 2009
- Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in miceBritish Journal of Pharmacology, 2008
- A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-ArachidonoylglycerolCell Chemical Biology, 2007
- GPR55: a new member of the cannabinoid receptor clan?British Journal of Pharmacology, 2007
- The orphan receptor GPR55 is a novel cannabinoid receptorBritish Journal of Pharmacology, 2007
- Control of Spasticity in a Multiple Sclerosis Model is mediated by CB1, not CB2, Cannabinoid ReceptorsBritish Journal of Pharmacology, 2007